These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 35227862)

  • 1. Enhanced safety surveillance of STAMARIL® yellow fever vaccine provided under the expanded access investigational new drug program in the USA.
    Rojas A; Hachey W; Kaur G; Korejwo J; Muhammad R
    J Travel Med; 2023 Nov; 30(7):. PubMed ID: 37000007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of anaphylaxis to YF-VAX® yellow fever vaccination: a retrospective evaluation of vaccine adverse event reports 1999-2018.
    McClenathan BM; Taylor JN; Housel LA; Ryan M
    J Travel Med; 2024 Mar; 31(2):. PubMed ID: 38051650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptance of yellow fever vaccine in the older traveller: a cohort study.
    Ferrara P; Masuet-Aumatell C; Ramon-Torrell JM
    Acta Biomed; 2021 Sep; 92(4):e2021098. PubMed ID: 34487067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling the large-scale yellow fever outbreak in Luanda, Angola, and the impact of vaccination.
    Zhao S; Stone L; Gao D; He D
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006158. PubMed ID: 29338001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance for yellow Fever virus in non-human primates in southern Brazil, 2001-2011: a tool for prioritizing human populations for vaccination.
    Almeida MA; Cardoso Jda C; Dos Santos E; da Fonseca DF; Cruz LL; Faraco FJ; Bercini MA; Vettorello KC; Porto MA; Mohrdieck R; Ranieri TM; Schermann MT; Sperb AF; Paz FZ; Nunes ZM; Romano AP; Costa ZG; Gomes SL; Flannery B
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2741. PubMed ID: 24625681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immunogenicity of primary yellow fever vaccination in infants and children: a systematic review, meta-analysis and meta-regression.
    Ferrara P; Losa L; Mantovani LG; Ambrosioni J; Agüero F
    J Travel Med; 2024 Apr; 31(3):. PubMed ID: 38438165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV.
    Motta E; Camacho LAB; Cunha M; de Filippis AMB; Lima SMB; Costa M; Pedro L; Cardoso SW; Cortes FH; Giacoia-Gripp CBW; Morata M; Nazer S; Moreira RI; de Oliveira Souza MC; Mendes YS; Souza Azevedo A; Dos Santos Alvez N; Grinsztejn B; Coelho LE
    AIDS; 2023 Dec; 37(15):2319-2329. PubMed ID: 37650759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of "Off-Target" Immune Modulation Induced by Live Attenuated Yellow Fever Vaccine.
    Xiang J; Chang Q; McLinden JH; Bhattarai N; Welch JL; Kaufman TM; Stapleton JT
    J Infect Dis; 2024 Mar; 229(3):786-794. PubMed ID: 36994927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual case of influenza-like illness after yellow fever vaccination.
    Lamson DM; Ramani R; Kleabonas M; Metcalfe M; Humphrey C; St George K
    J Clin Virol; 2014 May; 60(1):67-9. PubMed ID: 24594082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions of yellow fever emergency mass vaccinations among vulnerable groups in Uganda: A qualitative study.
    Huebl L; Nnyombi A; Kihumuro A; Lukwago D; Walakira E; Kutalek R
    PLoS Negl Trop Dis; 2024 May; 18(5):e0012173. PubMed ID: 38739650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine-derived yellow fever in an immunocompromised patient on anti-CD20-antibody therapy and its treatment with sofosbuvir.
    Weirauch T; Burger G; Cadar D; Gabriel M; Koepsell J; Schüttfort G; de Leuw P; Bickel M; Vehreschild MJGT; Wolf T; Wetzstein N
    Int J Infect Dis; 2024 Jun; 143():107017. PubMed ID: 38521450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inadvertent yellow fever vaccination of a patient with Crohn's disease treated with infliximab and methotrexate.
    Ekenberg C; Friis-Møller N; Ulstrup T; Aalykke C
    BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27571912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and Investigation of Risk Factors for Late-Relapsing Hepatitis After Yellow Fever.
    Rezende IM; McClure MA; Pereira LS; Fradico JRB; Cenachi ARC; Moura AS; Paladino LLA; Dutra MRT; Alves PA; Xavier MAP; Said RFDC; Ramalho DB; Gama TDP; Martins-Filho OA; Monath TP; Teixeira-Carvalho A; Drumond BP; LaBeaud AD;
    Clin Infect Dis; 2023 Aug; 77(4):565-573. PubMed ID: 37099356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-Label Yellow Fever and Hepatitis A Vaccination in Traveling Children.
    Muruzábal C; Vicente L; Escolano Taravillo L; Bravo Queipo de Llano B; Calvo C; García López Hortelano M
    Children (Basel); 2024 Mar; 11(3):. PubMed ID: 38539409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge and Attitudes Regarding the Vaccination of Brazilian Immigrants in Portugal: Risks When Returning to Their Country of Origin?
    Freitas IP; Igreja RP; Pacheco MR; Teodósio R
    Trop Med Infect Dis; 2024 Mar; 9(4):. PubMed ID: 38668528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidents of Practice.
    Int Dent J (Phila); 1903 Apr; 24(4):320-324. PubMed ID: 37913223
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidents of Practice.
    Int Dent J (Phila); 1903 May; 24(5):397. PubMed ID: 37913148
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidents of Practice.
    Int Dent J (Phila); 1903 Mar; 24(3):239-240. PubMed ID: 37913077
    [No Abstract]   [Full Text] [Related]  

  • 19. National review of reported Yellow fever vaccine incidents in the UK.
    Gnanadurai R; Campos-Matos I; Kanagarajah S; Geary K; Simons H; Patel D
    Travel Med Infect Dis; 2022; 47():102289. PubMed ID: 35227862
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.